Functional Imaging in Alzheimer's Disease: A Systematic Review and Meta‐Analysis of ASL‐MRI and FDG‐PET
Journal of Neuroimaging · 2025
DOI: 10.1111/jon.70080 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Neuroimaging, 2025. Verfasst von Mahla Radmard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institution, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Positron-Emission Tomography, Fluorodeoxyglucose F18, Magnetic Resonance Imaging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) and mild cognitive impairment (MCI) are two common conditions associated with cognitive decline. With global dementia cases rising, identifying the most accurate imaging method for diagnosis is essential.
Methods
Following Preferred Reporting Items for Systematic review and Meta‐Analysis Protocols, we systematically reviewed studies utilizing arterial spin labeling magnetic resonance imaging (ASL‐MRI) and [18F]‐2‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography (FDG‐PET) for neurodegenerative disorders. Searches in PubMed/MEDLINE, Scopus, and Embase led to 17 studies directly comparing these modalities for MCI/AD diagnosis. Seven studies met criteria for meta‐analysis based on interreader agreement and area under the curve (AUC) data. Meta‐analysis was performed using the R “Mada” package, with study heterogeneity assessed via the Zhou and Dendukuri approach.
Results
Meta‐analysis of seven studies showed FDG‐PET had a slightly higher AUC (0.864, sensitivity 0.81, specificity 0.80) compared to ASL‐MRI (AUC 0.836, sensitivity 0.73, specificity 0.80), but no statistically significant difference. Low heterogeneity was observed ( I 2 : 9.4% for FDG‐PET, 6.5% for ASL‐MRI). In MCI subgroup analysis, FDG‐PET outperformed ASL‐MRI with significantly higher sensitivity (0.90 vs. 0.75), specificity (0.91 vs. 0.73), and AUC (0.92 vs. 0.80, p < 0.001).
Conclusion
FDG‐PET and ASL‐MRI demonstrate comparable diagnostic accuracy for AD and MCI. Selection between modalities may depend on availability, cost, and safety considerations. Clinical Relevance/Application Both FDG‐PET and MRI‐ASL are effective at identifying MCI and AD, enabling accurate diagnosis. The choice of which modality to use may be addressed by cost, availability, and consideration of other potential diagnoses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institution, Baltimore, Maryland, USA.
- Diagnostic Radiology Department, Mansoura University, Mansoura, Egypt.
- Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Neuroradiology, MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Mahla Radmard, Vivek Yedavalli
Zitieren
APA
Radmard, M., Gad, M., Sheikhy, A., Dagher, R., Yedavalli, V., & Luna, L. P. (2025). Functional Imaging in Alzheimer's Disease: A Systematic Review and Meta‐Analysis of ASL‐MRI and FDG‐PET. Journal of Neuroimaging. https://doi.org/10.1111/jon.70080
Vancouver
Radmard M, Gad M, Sheikhy A, Dagher R, Yedavalli V, Luna LP. Functional Imaging in Alzheimer's Disease: A Systematic Review and Meta‐Analysis of ASL‐MRI and FDG‐PET. Journal of Neuroimaging. 2025. doi:10.1111/jon.70080
BibTeX
@article{Radmard2025,
author = {Radmard, Mahla and Gad, Mona and Sheikhy, Ali and Dagher, Richard and Yedavalli, Vivek and Luna, Licia P},
title = {Functional Imaging in Alzheimer's Disease: A Systematic Review and Meta‐Analysis of ASL‐MRI and FDG‐PET},
journal = {Journal of Neuroimaging},
year = {2025},
doi = {10.1111/jon.70080}
}
EUVIMED